Free Trial

Enliven Therapeutics (ELVN) Institutional Ownership

Enliven Therapeutics logo
$22.00 +0.53 (+2.45%)
As of 01:38 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Enliven Therapeutics (NASDAQ:ELVN)

Current
Institutional Ownership
Percentage
95.08%
Number of
Institutional Buyers
(last 12 months)
52
Total
Institutional Inflows
(last 12 months)
$164.88M
Number of
Institutional Sellers
(last 12 months)
27
Total
Institutional Outflows
(last 12 months)
$78.16M
Get ELVN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enliven Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ELVN Institutional Buying and Selling by Quarter

Enliven Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC43,714$984K0.0%+67.1%0.089%
2/17/2025 Soleus Capital Management L.P.75,405$1.70M0.1%-68.5%0.154%
2/17/2025 Two Sigma Investments LP14,620$329K0.0%-33.8%0.030%
2/17/2025 Stempoint Capital LP96,716$2.18M0.5%N/A0.198%
2/17/2025 Polar Capital Holdings Plc2,389,668$53.77M0.3%+267.6%4.891%
2/17/2025 ProShare Advisors LLC12,229$275K0.0%+29.5%0.025%
2/17/2025 Patient Square Capital LP224,038$5.04M1.9%+147.4%0.459%
2/17/2025 Nicholas Investment Partners LP157,635$3.55M0.3%-9.3%0.323%
2/17/2025 Millennium Management LLC50,804$1.14M0.0%+108.6%0.104%
2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.20,036$451K0.0%+3.7%0.041%
2/17/2025 Janus Henderson Group PLC1,331,877$30.00M0.0%+27.9%2.726%
2/17/2025 Graham Capital Management L.P.15,178$342K0.0%+67.3%0.031%
2/17/2025 Deutsche Bank AG30,516$687K0.0%+51.7%0.062%
2/17/2025 Brevan Howard Capital Management LP10,144$228K0.0%N/A0.021%
2/17/2025 Bank of America Corp DE34,187$769K0.0%-29.8%0.070%
2/17/2025 BNP Paribas Financial Markets4,991$112K0.0%N/A0.010%
2/17/2025 Ameriprise Financial Inc.35,059$789K0.0%N/A0.072%
2/17/2025 Ally Bridge Group NY LLC141,710$3.19M2.7%-39.7%0.290%
2/17/2025 5AM Venture Management LLC1,629,765$36.67M8.8%-7.0%3.336%
2/17/2025 Acuta Capital Partners LLC267,368$6.02M6.1%-9.8%0.547%
2/14/2025 Boxer Capital Management LLC671,358$15.11M1.3%N/A1.374%
2/14/2025 RA Capital Management L.P.848,986$19.10M0.3%-20.0%1.738%
2/14/2025 Northern Trust Corp331,500$7.46M0.0%+8.9%0.678%
2/14/2025 Artia Global Partners LP102,900$2.32M0.8%N/A0.211%
2/14/2025 Boothbay Fund Management LLC104,890$2.36M0.1%-21.0%0.215%
2/14/2025 Virtus ETF Advisers LLC3,091$70K0.0%-26.2%0.006%
2/14/2025 Lord Abbett & CO. LLC386,211$8.69M0.0%+20.3%0.790%
2/14/2025 Voya Investment Management LLC10,702$241K0.0%-8.1%0.022%
2/14/2025 Adage Capital Partners GP L.L.C.650,000$14.63M0.0%-18.8%1.330%
2/14/2025 Price T Rowe Associates Inc. MD13,627$307K0.0%+17.0%0.028%
2/14/2025 Tower Research Capital LLC TRC 1,598$36K0.0%+230.2%0.003%
2/14/2025 MetLife Investment Management LLC21,746$489K0.0%+6.3%0.045%
2/13/2025 Marshall Wace LLP41,382$931K0.0%-70.0%0.085%
2/13/2025 Barclays PLC64,563$1.45M0.0%+14.8%0.132%
2/13/2025 Legal & General Group Plc21,140$476K0.0%-2.9%0.043%
2/13/2025 Invesco Ltd.15,072$339K0.0%+3.5%0.031%
2/13/2025 FMR LLC6,495,871$146.16M0.0%+3.2%13.295%
2/13/2025 Federated Hermes Inc.117,552$2.65M0.0%N/A0.241%
2/13/2025 Wells Fargo & Company MN16,666$375K0.0%+49.9%0.034%
2/12/2025 ExodusPoint Capital Management LP8,900$200K0.0%N/A0.018%
Elon “obliterates” Bill Gates? (Ad)

All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them

2/12/2025 Geode Capital Management LLC762,718$17.17M0.0%+1.7%1.561%
2/12/2025 Wellington Management Group LLP80,916$1.82M0.0%+15.3%0.166%
2/12/2025 Pictet Asset Management Holding SA972,293$21.88M0.0%+16.3%1.990%
2/12/2025 JPMorgan Chase & Co.19,745$444K0.0%-5.1%0.040%
2/11/2025 Corebridge Financial Inc.17,500$394K0.0%-7.0%0.036%
2/11/2025 Vanguard Group Inc.1,975,655$44.45M0.0%+2.9%4.044%
2/11/2025 KLP Kapitalforvaltning AS4,300$97K0.0%N/A0.009%
2/11/2025 Intech Investment Management LLC16,322$367K0.0%N/A0.033%
2/10/2025 Swiss National Bank41,873$942K0.0%+13.9%0.086%
2/6/2025 Charles Schwab Investment Management Inc.261,888$5.89M0.0%+2.6%0.536%
2/4/2025 Bank of New York Mellon Corp89,575$2.02M0.0%-0.9%0.183%
1/31/2025 New York State Common Retirement Fund25,023$563K0.0%-9.0%0.051%
1/29/2025 Legato Capital Management LLC13,492$304K0.0%-7.5%0.028%
1/24/2025 China Universal Asset Management Co. Ltd.10,360$233K0.0%+14.0%0.021%
1/17/2025 SG Americas Securities LLC16,629$374K0.0%+66.1%0.034%
12/13/2024 Lord Abbett & CO. LLC321,055$8.20M0.0%N/A0.657%
11/27/2024 Franklin Resources Inc.20,151$559K0.0%N/A0.041%
11/19/2024 Barclays PLC56,217$1.44M0.0%+295.8%0.115%
11/16/2024 Geode Capital Management LLC750,208$19.16M0.0%+9.9%1.588%
11/15/2024 Barclays PLC56,217$1.44M0.0%+295.8%0.119%
11/15/2024 Jane Street Group LLC30,793$786K0.0%-41.9%0.065%
11/15/2024 Wellington Management Group LLP70,170$1.79M0.0%+107.0%0.149%
11/15/2024 State Street Corp745,944$19.05M0.0%+2.9%1.579%
11/15/2024 RA Capital Management L.P.1,061,233$27.10M0.3%-50.0%2.246%
11/15/2024 Patient Square Capital LP90,572$2.31M0.9%N/A0.192%
11/15/2024 Ikarian Capital LLC499,566$12.76M1.7%-14.8%1.058%
11/15/2024 Janus Henderson Group PLC1,041,724$26.61M0.0%+43.0%2.205%
11/15/2024 HighVista Strategies LLC112,459$2.87M1.0%-6.1%0.238%
11/14/2024 Verition Fund Management LLC10,610$271K0.0%N/A0.022%
11/14/2024 Walleye Capital LLC99,416$2.54M0.0%N/A0.210%
11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC26,168$668K0.0%+12.7%0.055%
11/14/2024 Ally Bridge Group NY LLC234,856$6.00M3.2%N/A0.497%
11/14/2024 Acuta Capital Partners LLC296,368$7.57M6.1%-25.5%0.627%
11/13/2024 FMR LLC6,296,179$160.80M0.0%+10.6%13.328%
11/13/2024 The Manufacturers Life Insurance Company17,282$441K0.0%+25.6%0.037%
11/12/2024 Charles Schwab Investment Management Inc.255,277$6.52M0.0%+10.4%0.540%
11/7/2024 First Turn Management LLC535,092$13.67M2.2%+29.5%1.133%
11/7/2024 Quest Partners LLC21,117$539K0.0%+1,226.4%0.045%
10/25/2024 China Universal Asset Management Co. Ltd.9,085$232K0.0%+64.4%0.019%
10/10/2024 Exchange Traded Concepts LLC7,483$191K0.0%-60.3%0.016%
10/3/2024 SG Americas Securities LLC10,013$256K0.0%N/A0.021%
8/15/2024 The Manufacturers Life Insurance Company13,764$322K0.0%N/A0.029%
8/14/2024 Marshall Wace LLP192,100$4.49M0.0%N/A0.408%
8/14/2024 Logos Global Management LP595,000$13.91M1.1%-62.2%1.265%
8/14/2024 HighVista Strategies LLC119,789$2.80M1.0%-5.6%0.255%
8/8/2024 First Turn Management LLC413,243$9.66M1.6%N/A0.879%
8/8/2024 Nicholas Investment Partners LP56,072$1.31M0.1%N/A0.119%
8/8/2024 American Century Companies Inc.27,651$646K0.0%+44.7%0.059%
8/6/2024 Quest Partners LLC1,592$37K0.0%+87.3%0.003%
8/1/2024 Rhumbline Advisers49,627$1.16M0.0%+29.9%0.105%
Elon “obliterates” Bill Gates? (Ad)

All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them

7/26/2024 Bank of New York Mellon Corp114,109$2.67M0.0%+49.2%0.243%
5/16/2024 California State Teachers Retirement System19,141$337K0.0%-5.8%0.041%
5/16/2024 Janus Henderson Group PLC713,911$12.60M0.0%+74.8%1.519%
5/16/2024 Blackstone Inc.25,191$443K0.0%N/A0.054%
5/15/2024 Baker BROS. Advisors LP114,833$2.02M0.0%N/A0.244%
5/14/2024 EntryPoint Capital LLC9,510$167K0.1%N/A0.020%
5/10/2024 Vanguard Group Inc.1,183,266$20.81M0.0%-3.9%2.517%
5/7/2024 SG Americas Securities LLC9,430$166K0.0%-30.2%0.020%
4/29/2024 China Universal Asset Management Co. Ltd.7,952$140K0.0%+67.0%0.017%
2/13/2024 Tower Research Capital LLC TRC5,485$76K0.0%-18.8%0.013%
(Data available from 1/1/2016 forward)

ELVN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELVN shares?

During the previous two years, 88 institutional investors and hedge funds held shares of Enliven Therapeutics. The most heavily invested institutionals were FMR LLC ($146.16M), Polar Capital Holdings Plc ($53.77M), Commodore Capital LP ($47.93M), VR Adviser LLC ($45.52M), Vanguard Group Inc. ($44.45M), Fairmount Funds Management LLC ($42.16M), and 5AM Venture Management LLC ($36.67M).Learn more on ELVN's institutional investors.

What percentage of Enliven Therapeutics stock is owned by institutional investors?

95.08% of Enliven Therapeutics stock is owned by institutional investors. Learn more on ELVN's institutional investor holdings.

Which institutional investors have been buying Enliven Therapeutics stock?

Of the 68 institutional investors that purchased Enliven Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($3.96M), Commodore Capital LP ($2.35M), Fairmount Funds Management LLC ($1.92M), Polar Capital Holdings Plc ($1.74M), Janus Henderson Group PLC ($908.57K), Boxer Capital LLC ($710.64K), and Boxer Capital Management LLC ($671.36K).

How much institutional buying is happening at Enliven Therapeutics?

Institutional investors have bought a total of 16,160,881 shares in the last 24 months. This purchase volume represents approximately $361.18M in transactions.

Which Enliven Therapeutics major shareholders have been selling company stock?

Of the 33 institutional investors that sold Enliven Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RA Capital Management L.P. ($1.27M), Logos Global Management LP ($979.22K), FMR LLC ($325.40K), Soleus Capital Management L.P. ($164.30K), BML Capital Management LLC ($162.18K), Adage Capital Partners GP L.L.C. ($150K), and Acuta Capital Partners LLC ($130.33K).

How much institutional selling is happening at Enliven Therapeutics?

Institutional investors have sold a total of 3,783,025 shares in the last 24 months. This volume of shares sold represents approximately $86.06M in transactions.



This page (NASDAQ:ELVN) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners